Julia Ney1, Daren K Heyland2, Karin Amrein3, Gernot Marx4, Oliver Grottke5, Michael Choudrakis6, Teresa Autschbach7, Aileen Hill5, Patrick Meybohm8, Carina Benstoem4, Andreas Goetzenich7, Christina Fitzner4, Christian Stoppe9. 1. Department of Intensive Care Medicine and 3CARE, Medical Faculty, RWTH Aachen University, Aachen, Germany. Electronic address: ney.julia1@gmail.com. 2. Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada. 3. Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria. 4. Department of Intensive Care Medicine and 3CARE, Medical Faculty, RWTH Aachen University, Aachen, Germany. 5. Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. 6. Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. 7. Department of Thoracic, Cardiac and Vascular Surgery, Medical Faculty, RWTH Aachen University, Aachen, Germany. 8. Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany. 9. Department of Intensive Care Medicine and 3CARE, Medical Faculty, RWTH Aachen University, Aachen, Germany. Electronic address: christian.stoppe@gmail.com.
Abstract
BACKGROUND & AIMS: Recent studies indicate that vitamin D deficiency is associated with increased morbidity and mortality in critically ill patients. Knowledge about the functional role and clinical relevance of vitamin D for patients undergoing cardiac surgery is sparse. Therefore, we investigated the clinical significance of vitamin D levels on outcome of cardiac surgery patients. METHODS: 92 patients undergoing elective cardiac surgery with cardiopulmonary arrest were included in this prospective observational pilot study. 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels were measured prior to surgery, immediately postoperatively as well as 6, 12 and 24 h after surgery. We assessed postoperative organ dysfunctions, infections and death until hospital discharge. RESULTS: The serum concentration of 1,25(OH)2D significantly decreased intraoperatively by 29.3% (p < 0.001) and was significantly lower at any postoperative time point compared to baseline values, whereas 25OHD levels did not show significant changes during the observation period. Coronary artery bypass graft (CABG) patients had significant higher baseline 1,25(OH)2D values than patients with valve surgery (39.7 ± 13.9 ng/l vs. 30.1 ± 14.1 ng/l, p = 0.010) or CABG + valve surgery (39.7 ± 13.9 ng/l vs. 32.6 ± 11.8 ng/l, p = 0.044). Our data showed a significant odds ratio to develop postoperative organ dysfunction (OR 0.95; p = 0.009) and PCT levels ≥5 μg/l (OR 0.94; p = 0.046) for every ng/l increment in 1,25(OH)2D, when performing multivariable analysis and after adjusting for preoperative illness and demographics. In addition, multivariable-adjusted statistical analyses revealed that patients stayed significantly shorter on ICU (-0.21 h; p = 0.001) and in hospital (-2.6 days; p = 0.009) for every ng/l increment in 1,25(OH)2D. CONCLUSION: Our data highlight important evidence about the clinical significance of 1,25(OH)2D levels in cardiac surgery patients. Higher levels were associated with significantly less postoperative organ dysfunctions, elevated PCT levels, death and prolonged hospital stay. 1,25(OH)2D levels decreased significantly intra- and postoperatively, while serum levels of 25OHD did not. TRIAL REGISTRATION: clinicaltrials.gov (NCT02488876), registered May 1, 2015.
BACKGROUND & AIMS: Recent studies indicate that vitamin D deficiency is associated with increased morbidity and mortality in critically illpatients. Knowledge about the functional role and clinical relevance of vitamin D for patients undergoing cardiac surgery is sparse. Therefore, we investigated the clinical significance of vitamin D levels on outcome of cardiac surgery patients. METHODS: 92 patients undergoing elective cardiac surgery with cardiopulmonary arrest were included in this prospective observational pilot study. 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels were measured prior to surgery, immediately postoperatively as well as 6, 12 and 24 h after surgery. We assessed postoperative organ dysfunctions, infections and death until hospital discharge. RESULTS: The serum concentration of 1,25(OH)2D significantly decreased intraoperatively by 29.3% (p < 0.001) and was significantly lower at any postoperative time point compared to baseline values, whereas 25OHD levels did not show significant changes during the observation period. Coronary artery bypass graft (CABG) patients had significant higher baseline 1,25(OH)2D values than patients with valve surgery (39.7 ± 13.9 ng/l vs. 30.1 ± 14.1 ng/l, p = 0.010) or CABG + valve surgery (39.7 ± 13.9 ng/l vs. 32.6 ± 11.8 ng/l, p = 0.044). Our data showed a significant odds ratio to develop postoperative organ dysfunction (OR 0.95; p = 0.009) and PCT levels ≥5 μg/l (OR 0.94; p = 0.046) for every ng/l increment in 1,25(OH)2D, when performing multivariable analysis and after adjusting for preoperative illness and demographics. In addition, multivariable-adjusted statistical analyses revealed that patients stayed significantly shorter on ICU (-0.21 h; p = 0.001) and in hospital (-2.6 days; p = 0.009) for every ng/l increment in 1,25(OH)2D. CONCLUSION: Our data highlight important evidence about the clinical significance of 1,25(OH)2D levels in cardiac surgery patients. Higher levels were associated with significantly less postoperative organ dysfunctions, elevated PCT levels, death and prolonged hospital stay. 1,25(OH)2D levels decreased significantly intra- and postoperatively, while serum levels of 25OHD did not. TRIAL REGISTRATION: clinicaltrials.gov (NCT02488876), registered May 1, 2015.
Authors: Quirin Notz; Johannes Herrmann; Tobias Schlesinger; Peter Kranke; Magdalena Sitter; Philipp Helmer; Jan Stumpner; Daniel Roeder; Karin Amrein; Christian Stoppe; Christopher Lotz; Patrick Meybohm Journal: Clin Nutr Date: 2021-03-07 Impact factor: 7.643
Authors: Tyler Barker; Heidi T May; John R Doty; Donald L Lappe; Kirk U Knowlton; John Carlquist; Kristin Konery; Shannon Inglet; Ben Chisum; Oxana Galenko; Jeffrey L Anderson; Joseph B Muhlestein Journal: Physiol Rep Date: 2021-02
Authors: Emma A Hurst; Richard J Mellanby; Ian Handel; David M Griffith; Adriano G Rossi; Timothy S Walsh; Manu Shankar-Hari; Jake Dunning; Natalie Z Homer; Scott G Denham; Kerri Devine; Paul A Holloway; Shona C Moore; Ryan S Thwaites; Romit J Samanta; Charlotte Summers; Hayley E Hardwick; Wilna Oosthuyzen; Lance Turtle; Malcolm G Semple; Peter J M Openshaw; J Kenneth Baillie; Clark D Russell Journal: BMJ Open Date: 2021-10-22 Impact factor: 2.692
Authors: Johannes Menger; Zheng-Yii Lee; Quirin Notz; Julia Wallqvist; M Shahnaz Hasan; Gunnar Elke; Martin Dworschak; Patrick Meybohm; Daren K Heyland; Christian Stoppe Journal: Crit Care Date: 2022-09-06 Impact factor: 19.334
Authors: Ibrahim A Albahlol; Abdulrahman H Almaeen; Abdulrahman A Alduraywish; Umar F Dar; Tarek H El-Metwally Journal: Int J Med Sci Date: 2020-10-18 Impact factor: 3.738